LOL. These two statements are 100% coherent. BIT and I are in total agreement that BIT225 is not worth pursuing.
The question for the shareholders is to determine if the new preclinical programs make BIT worth more than $40 million. I don't think they do, but people are welcome to make an argument why they think the preclinical programs are worth at least this much.
$10 Billion Deal, page-2879
-
- There are more pages in this discussion • 10,508 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 1.9¢ | $6.308K | 311.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1673695 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 93000 | 2 |
View Market Depth
| Last trade - 15.39pm 08/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |